• Explore /
  • Poster
  • / Postoperative complications following neoadjuvant therapy and surgery in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501).

Postoperative complications following neoadjuvant therapy and surgery in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501).

Abstract Poster

Authors

Rebecca Snyder

Rebecca A Snyder

The University of Texas MD Anderson Cancer Center, Houston, TX

Rebecca A Snyder , Tyler J. Zemla , Qian Shi , Diana I. Segovia , Syed Ahmad , Eileen Mary O'Reilly , Joseph M. Herman , Matthew H. G. Katz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02839343

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 664)

DOI

10.1200/JCO.2024.42.3_suppl.664

Abstract #

664

Poster Bd #

L13

Abstract Disclosures

Similar Posters

First Author: Derek B. Grose

First Author: Thomas J. George

First Author: Sherise C. Rogers

Poster

2023 ASCO Gastrointestinal Cancers Symposium

An adaptive approach to neoadjuvant therapy to maximize resection rates for pancreatic adenocarcinoma: A phase II trial.

An adaptive approach to neoadjuvant therapy to maximize resection rates for pancreatic adenocarcinoma: A phase II trial.

First Author: Davendra Sohal